Cordova Ashley

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
17
Insider Sells Sum
$4M

Insider Activity of Cordova Ashley

According to the SEC Form 4 filings, Cordova Ashley, being in a position of

  1. Chief Financial Officer at NovoCure Limited,
    оver the last 12 months, has bought 0 shares, and sold 688 shares for $13,857,
    over all time since 2020-11-02, has bought 0 shares, and sold 37989 shares for $4M.

The largest sale of all time was on 2021-08-12 and amounted to 16559 shares of NovoCure Limited for $2.33M.

Biography of Cordova Ashley

No biography is available at this moment.

2024-08-02SaleNovoCure Limited
NVCR
Chief Financial Officer
688
0.0006%
$20.14$13,857-14.41%
2023-09-01SaleNovoCure Limited
NVCR
Chief Financial Officer
883
0.0008%
$21.82$19,265-33.09%
2023-08-02SaleNovoCure Limited
NVCR
Chief Financial Officer
1,144
0.0011%
$30.25$34,607-49.96%
2023-03-03SaleNovoCure Limited
NVCR
Chief Financial Officer
5,505
0.0051%
$76.16$419,258-73.53%
2023-03-03SaleNovoCure Limited
NVCR
Chief Financial Officer
4,730
0.0044%
$76.16$360,234-73.53%
2023-03-02SaleNovoCure Limited
NVCR
Chief Financial Officer
1,055
0.001%
$75.28$79,418-71.96%
2023-03-01SaleNovoCure Limited
NVCR
Chief Financial Officer
2,198
0.0021%
$76.36$167,845-71.92%
2022-09-02SaleNovoCure Limited
NVCR
Chief Financial Officer
885
0.0008%
$79.04$69,948-9.1%
2022-03-08SaleNovoCure Limited
NVCR
Chief Financial Officer
759
0.0007%
$70.10$53,206+11.28%
2022-03-03SaleNovoCure Limited
NVCR
Chief Financial Officer
556
0.0005%
$70.41$39,146+4.71%
2021-11-02SaleNovoCure Limited
NVCR
Chief Financial Officer
209
0.0002%
$107.28$22,421-27.59%
2021-09-02SaleNovoCure Limited
NVCR
Chief Financial Officer
828
0.0008%
$138.23$114,456-42.95%
2021-08-12SaleNovoCure Limited
NVCR
Chief Financial Officer
16,559
0.0158%
$140.96$2.33M-43.37%
2021-03-08SaleNovoCure Limited
NVCR
Chief Financial Officer
765
0.0008%
$130.81$100,067+1.98%
2021-03-04SaleNovoCure Limited
NVCR
Chief Financial Officer
567
0.0006%
$137.55$77,993-2.79%
2021-03-02SaleNovoCure Limited
NVCR
Chief Financial Officer
428
0.0004%
$152.05$65,079-14.45%
2020-11-02SaleNovoCure Limited
NVCR
Chief Financial Officer
230
0.0002%
$117.41$27,005+40.25%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.